A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance.
Patchsung M, Homchan A, Aphicho K, Suraritdechachai S, Wanitchanon T, Pattama A, Sappakhaw K, Meesawat P, Wongsatit T, Athipanyasilp A, Jantarug K, Athipanyasilp N, Buahom J, Visanpattanasin S, Niljianskul N, Chaiyen P, Tinikul R, Wichukchinda N, Mahasirimongkol S, Sirijatuphat R, Angkasekwinai N, Crone MA, Freemont PS, Joung J, Ladha A, Abudayyeh O, Gootenberg J, Zhang F, Chewapreecha C, Chanarat S, Horthongkham N, Pakotiprapha D, Uttamapinant C
CRISPR J. 2022 Nov 11. doi: 10.1089/crispr.2022.0048.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
163911 | pET28a-MH6-Bsu | Expresses Bsu large fragment for affinity purification |
163912 | pET28a-gp32-H6 | Expresses T4 gp32 for bacterial expression and affinity purification |
163913 | pET28a-uvsX-H6 | Expresses uvsX for bacterial expression and affinity purification |
163914 | pET28a-MH6-uvsY | Expresses uvsY for bacterial expression and affinity purification |